Can-Fite BioPharma Ltd. (CANF): Shares Outstanding

Annual figures by period end, from SEC filings.

Figures left out. The filed Shares Outstanding for the year ended 2023-12-31 is not shown: shares outstanding out of scale with weighted shares. That usually means the filing tagged the figure in the wrong unit.

2.62M
As of 2025-12-31
-85.2%
3-year compound annual growth
-64.5%
5-year compound annual growth
815.75M2019-12-31: 120.65M2020-12-31: 463.77M2021-12-31: 815.75M2022-12-31: 815.75M2024-12-31: 994.4K2025-12-31: 2.62M2.62M
2019-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-312.62M+163.3%2026-03-26, Balance as of period end
2024-12-31994.4Kn/a2026-03-26, Balance as of period end
No annual figure between 2022-12-31 and 2024-12-31.
2022-12-31815.75M0.0%2024-03-28, Balance as of period end
2021-12-31815.75M+75.9%2023-03-30, Balance as of period end
2020-12-31463.77Mn/c2022-03-24, Balance as of period end
2019-12-31120.65Mn/a2021-03-25, Balance as of period end